Health Tech
Jennifer Bath, chief executive officer at Immunoprecise Antibodies Ltd., discusses the company’s potentially groundbreaking Covid-19 antibody treatment on.
Credit Bloomberg Technology
Please support our Sponsors -
Jennifer Bath, chief executive officer at Immunoprecise Antibodies Ltd., discusses the company’s potentially groundbreaking Covid-19 antibody treatment on.
Credit Bloomberg Technology